SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-07-118165
Filing Date
2007-05-18
Accepted
2007-05-18 06:02:21
Documents
8
Period of Report
2007-05-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K FOR BIOSITE INCORPORATED d8k.htm 8-K 35747
2 AGREEMENT AND PLAN OF MERGER dex21.htm EX-2.1 434723
3 NON-COMPETITION, NON-DISCLOSURE AND INTELLECTUAL AGREEMENT - KIM D BLICKENSTAFF dex101.htm EX-10.1 55659
4 NON-COMPETITION, NON-DISCLOSURE AND INTELLECTUAL AGREEMENT -KENNETH F. BUECHLER dex102.htm EX-10.2 55698
5 NON-COMPETITION, NON-DISCLOSURE AND INTELLECTUAL AGREEMENT - GUNARS E. VALKIRS dex103.htm EX-10.3 56107
6 AMENDMENT NO. 4 TO RIGHTS AGREEMENT dex104.htm EX-10.4 26913
7 PRESS RELEASE OF BIOSITE INCORPORATED AND INVERNESS MEDICAL INNOVATIONS, INC. dex991.htm EX-99.1 16553
8 GRAPHIC g94097ch1.jpg GRAPHIC 14452
  Complete submission text file 0001193125-07-118165.txt   703185
Mailing Address 11030 ROSELLE ST SAN DIEGO CA 92121
Business Address 11030 ROSELLE ST SAN DIEGO CA 92121 6194554808
BIOSITE INC (Filer) CIK: 0000834306 (see all company filings)

IRS No.: 330288606 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21873 | Film No.: 07863044
SIC: 2835 In Vitro & In Vivo Diagnostic Substances